tetracaine hydrochloride solution
nucare pharmaceuticals,inc. - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv) - for procedures in which a rapid and short-acting topical ophthalmic anesthetic is indicated such as in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, suture removal from the cornea, other short corneal and conjunctival procedures. should not be used by the patient without physician supervision, or in those persons showing hypersensitivity to any component of this preparation. this product should never be prescribed for the patient’s own use.
tetracain 10 mg/ml picături oftalmice, soluţie
liqvor saÎ - tetracainum - picături oftalmice, soluţie - 10 mg/ml
tetracain 1% picături oftalmice, soluţie
liqvor saÎ - tetracainum - picături oftalmice, soluţie - 1%
minims tetracainehydrochloride 10 mg/ml, oogdruppels, oplossing
bausch health ireland limited 3013 lake drive, citywest business campus d24 ppt3 dublin 24 (ierland) - tetracaine hydrochloride 10 mg/ml - oogdruppels, oplossing - water, gezuiverd ; zoutzuur (e 507), - tetracaine
minims tetracainehydrochloride 5 mg/ml, oogdruppels, oplossing
bausch health ireland limited 3013 lake drive, citywest business campus d24 ppt3 dublin 24 (ierland) - tetracaine hydrochloride 5 mg/ml - oogdruppels, oplossing - water, gezuiverd ; zoutzuur (e 507), - tetracaine
kovanaze- tetracaine hydrochloride and oxymetazoline hydrochloride spray
st. renatus - tetracaine hydrochloride (unii: 5nf5d4opci) (tetracaine - unii:0619f35cgv), oxymetazoline hydrochloride (unii: k89mj0s5vy) (oxymetazoline - unii:8vln5b44zy) - tetracaine hydrochloride 30 mg in 1 ml - kovanaze tm is indicated for regional anesthesia when performing a restorative procedure on teeth 4-13 and a-j in adults and children who weigh 40 kg or more. kovanaze is contraindicated in patients with a history of allergy to or intolerance of tetracaine, benzyl alcohol, other ester local anesthetics, p -aminobenzoic acid (paba), oxymetazoline, or any other component of the product [see warnings and precautions ( 5.5)] . risk summary limited published data on tetracaine use in pregnant women are not sufficient to inform any risks. published epidemiologic studies of nasal oxymetazoline used as a decongestant during pregnancy do not identify a consistent association with any specific malformation or pattern of malformations [see data] . in animal reproduction and development studies, oxymetazoline given subcutaneously to rats during the period of organogenesis caused structural abnormalities at a dose approximately 7.6 times the exposure
minims tetracaine chlorhydrate 10 mg/ml collyre sol. récip. unidose
bausch + lomb ireland - chlorhydrate de tétracaïne 10 mg/ml - eq. tétracaïne 8,79 mg/ml - collyre en solution - 10 mg/ml - chlorhydrate de tétracaïne 10 mg/ml - tetracaine
tetracaina cloridrato
farma 3 srl - tetracaina - tetracaina
tetracaina lainco 7,5 mg/g 200 tubs de 6 g
tetracaïna. - pomada
tetracaina lainco 7,5 mg/g 200 tubs de 25 g
tetracaïna. - pomada